He did his Ph.D. at the Institute of Pathology of the Helmholtz Zentrum München, Germany, on the application of mass spectrometry imaging (MSI) in cancer research. Later, at the Center of Proteomics and Metabolomics, Leiden University Medical Center, he focused on the computational analysis of MSI datasets for the study of intratumor heterogeneity.